Delivery Order SPE2DB22D1202-SPE2DB24FUSA7
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $5,406.69 under the Defense Logistics Agency's (DLA) Indefinite Delivery Contract (IDC). The contract, which runs through December 2024, is for the supply of PROVOCHOLINE 100 MG VIALS, a medical product, to support the DLA's Troop Support Medical program. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Provocholine inhalation solution in 18 mL packages. The $4,426.65 delivery order has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies to Department of...
- This federal contract award is a delivery order with a firm fixed price of $3,998.64 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of PROVOCHOLINE 100 MG VIALS. The contract has an ultimate completion date of June 6, 2025 and was awarded on June 5, 2025 by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,670.65 order is for the provision of Provocholine Inhalation Solution, Pack 18ML, a pharmaceutical product. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,295.11, is for the delivery of 4568618822 PROVOCHOLINE 100 MG VIALS. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency issued a $11,638.94 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Provocholine 100 mg vials, with an ultimate completion date of March 4, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing...
- <p>The Defense Logistics Agency issued a $5,549.72 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Provocholine 100 mg vials, with an ultimate completion date of March 9, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $7,077.65, is for the supply of Provocholine inhalation solution. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which supports the provision of a wide range of pharmaceutical...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 9, 2026, for Provocholine inhalation solution, 18 mL pack, with a ceiling value of $8,357.49, under a firm fixed-price contract. Ultimate completion date is April 10, 2026. Place of performance is Conshohocken, PA. The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999 through December 2026, which serves as a comprehensive global...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies. The contract has a ceiling value of $1,558.62 and a performance period through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUSA7Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563815616 PROVOCHOLINE 100 MG VIALS. The total potential value of the contract is $1,153.48, with a completion date of March 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for delivering pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This specific delivery order does not have a set-aside designation.
Generated 5/30/24, 9:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/29/24 |